Call Options

8 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q2 2022

Aug 15, 2022

SELL
$224.73 - $338.64 $337,095 - $507,960
-1,500 Closed
0 $0
Q1 2022

May 16, 2022

BUY
$277.25 - $366.29 $388,150 - $512,806
1,400 Added 1400.0%
1,500 $497,000
Q2 2021

Aug 16, 2021

SELL
$262.71 - $351.17 $4.18 Million - $5.58 Million
-15,900 Reduced 99.38%
100 $31,000
Q4 2020

Feb 16, 2021

SELL
$251.88 - $324.2 $8.29 Million - $10.7 Million
-32,900 Reduced 67.28%
16,000 $5.18 Million
Q3 2020

Nov 13, 2020

BUY
$255.22 - $317.0 $3.75 Million - $4.66 Million
14,700 Added 42.98%
48,900 $13.5 Million
Q2 2020

Aug 14, 2020

BUY
$141.4 - $257.09 $3.11 Million - $5.66 Million
22,000 Added 180.33%
34,200 $8.26 Million
Q1 2020

May 15, 2020

SELL
$130.51 - $196.01 $365,428 - $548,828
-2,800 Reduced 18.67%
12,200 $1.78 Million
Q3 2018

Nov 14, 2018

BUY
$354.53 - $449.75 $5.32 Million - $6.75 Million
15,000 New
15,000 $6.75 Million

Others Institutions Holding ABMD

About ABIOMED INC


  • Ticker ABMD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 45,460,900
  • Description
  • Abiomed, Inc. engages in the research, development, and sale of medical devices to assist or replace the pumping function of the failing heart. It also provides a continuum of care to heart failure patients. The company offers Impella 2.5, a percutaneous micro heart pump with integrated motor and sensors; and Impella CP, a device for use by inte...
More about ABMD
Track This Portfolio

Track Parallax Volatility Advisers, L.P. Portfolio

Follow Parallax Volatility Advisers, L.P. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Parallax Volatility Advisers, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Parallax Volatility Advisers, L.P. with notifications on news.